Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Sep 01, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-003620.pdf 0001950047-23-003620.xls
Aug 25, 2023	SC TO-T	Tender offer schedule and amendment filed by a third party.	View HTML 0001104659-23-095116.pdf 0001104659-23-095116.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000030.pdf 0001968202-23-000030.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000028.pdf 0001968202-23-000028.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000029.pdf 0001968202-23-000029.xls
Aug 25, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000031.pdf 0001968202-23-000031.xls
Aug 24, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001732.pdf
Aug 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000022.pdf 0001968202-23-000022.xls
Aug 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000023.pdf 0001968202-23-000023.xls
Aug 23, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001731.pdf

Data provided by Kaleidoscope.

Investors & Media